Skip to content

Clinical trials

Phase 2 Bacterial Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacterial Infections Phase: Phase 2 Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20041
20051
20062
20074
20081
20104
20114
20133
20143
20152
20162
20183
20211
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Withdrawn3
Unknown status2
Active, not recruiting2
Terminated2
Recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
National Institute of Allergy and Infectious Diseases (NIAID)3
Cardeas Pharma2
Furiex Pharmaceuticals, Inc2
Merck Sharp & Dohme LLC2
National Center for Research Resources (NCRR)2
U.S. Army Medical Research and Development Command2
Azienda Sanitaria Universitaria Friuli Centrale1
Biomedical Advanced Research and Development Authority1
Cellceutix Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacterial Infections42
Pneumonia8
Pneumonia, Bacterial6
Gram-Positive Bacterial Infections5
Infections5
Respiratory Tract Diseases4
Respiratory Tract Infections4
Abscess3
Cellulitis3
Communicable Diseases3

Trials

Showing 76 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.